Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Jun 11.
Published in final edited form as: J Mol Biol. 2020 Dec 31;433(12):166794. doi: 10.1016/j.jmb.2020.166794

Biochemical timekeeping via reentrant phase transitions.

Bede Portz 1, James Shorter 1,*
PMCID: PMC8154630  NIHMSID: NIHMS1664424  PMID: 33387533

Abstract

Appreciation for the role of liquid-liquid phase separation in the functional organization of cellular matter has exploded in recent years. More recently there has been a growing effort to understand the principles of heterotypic phase separation, the demixing of multiple proteins and nucleic acids into a single functional condensate. A phase transition is termed reentrant if it involves the transformation of a system from one state into a macroscopically similar or identical state via at least two phase transitions elicited by variation of a single parameter. Reentrant liquid-liquid phase separation can occur when the condensation of one species is tuned by another. Reentrant phase transitions have been modeled in vitro using protein and RNA mixtures. These biochemical studies reveal two features of reentrant phase separation that are likely important to functional cellular condensates: (1) the ability to generate condensates with layered functional topologies, and (2) the ability to generate condensates whose composition and duration are self-limiting to enable a form of biochemical timekeeping. We relate these biochemical studies to potential cellular examples and discuss how layered topologies and self-regulation may impact key biological processes.

Keywords: phase separation, reentrant phase transitions, disordered proteins, transcription, RNA, condensates

Reentrant phase transitions of protein and RNA

Biomolecular condensates form by phase separation to functionally organize proteins and nucleic acids without an encompassing membrane [1,2]. Aberrant phase transitions underlie disease states in conditions as diverse as neurodegeneration [36], viral infection [710], developmental disorders [11,12], and cancer [1315]. Conversely, functional and adaptive roles for condensates are also being rapidly identified across kingdoms and include RNA localization [1618], signal transduction [19,20], genome organization [2123], gene transcription [2427], environmental sensing [28,29], cell fate decision making [30,31], chaperoning complex assembly [29,32] and accelerating biochemical reactions [33]. In physics, a system experiences reentrant phase transitions when variation of a single thermodynamic parameter results in two (or more) phase transitions that enable attainment of a state, which is macroscopically similar or identical to the original state in terms of the number of different phases and their respective material properties [34,35] (Figure 1). In biology, some biomolecular condensates form and dissolve via a reentrant liquid-liquid phase separation (LLPS) whereby the condensation of one molecule is tuned by the relative concentration of another [36] (Figure 1). An archetypical example is the phase separation of an RNA-binding protein (RBP) tuned by a cognate RNA (Figure 1). Here, the system returns to a macroscopically similar state, consisting of a single light phase, that differs on the molecular level from the initial state in terms of its components and their interactions (Figure 1). Reentrant phase behavior is thus ideally suited to engender condensates that regulate the duration of their own existence and time the biochemical processes they facilitate.

Figure 1. Reentrant phase separation of a heterotypic condensate.

Figure 1.

For a homotypic condensate (top panel) composed a single RNA binding protein (RBP), a phase transition occurs (red arrow) when [RBP] > Csat, leading to a transition from a one-phase to a two-phase solution consisting of a light phase depleted of the RBP and a RBP rich dense phase. Increasing the RBP concentrations leads to an increase in the volume fraction of the dense phase, depicted by increased condensate size and number as a function of RBP concentration. An example of a heterotypic condensate (bottom panel) composed of the same RBP and a co-condensing RNA. Here, [RBP] < Csat and is fixed. Increasing the concentration of RNA drives an initial phase transition (left red arrow) and the formation of heterotypic condensates composed of both the RBP and RNA. As RNA concentration increases, condensates dissolve via a second, reentrant phase transition (right red arrow), leading to a one-phase solution macroscopically similar to the first. At the molecular level, this solution consists of RBP + RNA complexes, and unbound RNA.

Homotypic LLPS results in the switchlike demixing of a biomolecule into a high-concentration dense phase and low-concentration light phase [37]. Demixing occurs when the saturation concentration, Csat, of the molecule is reached [37] (Figure 1). This process is thought to underlie the formation of a growing list of membraneless organelles (MLOs) in cells both in the nucleus and cytoplasm [1,38]. In cells, however, MLOs are highly heterotypic, and are composed of a complex mixture of both proteins and RNA [39,40]. Heterotypic condensates containing RNA-binding proteins (RBPs) and RNA can exhibit reentrant phase behavior [36,41] (Figure 1). In such systems RNA can drive the phase transition of a RBP at concentrations where the RBP alone would not condense (Figure 1). The further addition of RNA leads to a second phase transition whereby condensates dissolve resulting in solution consisting of only the ‘light phase’. Here, the initial and final solutions are macroscopically similar, consisting of only one phase with similar material properties, but differ on the molecular level (Figure 1). Reentrant LLPS can manifest as condensates with spatial organization in the form of layered topologies [42,43]. Additionally, reentrant LLPS could enable temporal regulation in the form of metastable condensates whose existence is self-limiting [36], governed by the synthesis or decay of a second molecule that tunes the phase behavior of the first (Figure 2).

Figure 2. A model for self-limited transcription via reentrant LLPS.

Figure 2.

1. An initial enhancer-promoter contact is formed involving the factor YY1, leading to Pol II recruitment and gene activation (right). 2. As more RNA is produced, it entraps YY1 and the high local concentration nucleates a transcriptional condensate rich in YY1 (bottom center). 3. Increasing mRNA production leads to a reentrant phase transition resulting in dissolution of the transcriptional condensate (left). 4. The reduced local YY1 concentration leads to a loss of DNA binding, and the gene is shut off (top). Thus, phase separation peaks after nucleation and wanes as the RNA concentration increases providing temporal regulation of transcription (indicated as a clock).

Reentrant behavior will emerge for multicomponent systems where homotypic and heterotypic interactions are in competition and are thus not limited to protein and RNA mixtures [4447]. Examples of reentrant LLPS have been reconstituted biochemically, with compelling implications for cellular condensates. One such example is the prion-like domain (PrLD) containing RBP, FUS [4852]. Chromosomal translocations can result in the PrLD of FUS being fused to DNA-binding domains, creating an oncogenic fusion protein that drives pathologic gene expression programs in sarcoma [53,54].The PrLD of FUS can interact with the disordered C-terminal domain (CTD) of RNA polymerase II (Pol II) to activate transcription [5558]. FUS, and its isolated PrLD, are archetypal examples of protein LLPS both in vitro and in cells [3,58,59]. FUS LLPS is also an example of reentrant LLPS modulated by RNA [55,58,60]. RNA lowers the Csat of FUS, driving phase separation at lower FUS concentrations [55,58,60]. However, increasing amounts of RNA relative to FUS also serve to inhibit FUS condensation [58]. Notably, RNA also regulated the association between FUS and the Pol II CTD [55,58]. In this sense, FUS:CTD interactions could initially elicit the production of mRNA, further stabilizing the FUS:CTD interaction via the formation of FUS condensates that recruit Pol II, driving more transcription via a feed-forward mechanism. Conversely, as RNA is transcribed and accumulates locally, the FUS condensate could be dissolved, creating a feedback mechanism.

Specific RNAs could also play roles in regulating reentrant phase behavior in cells. This phenomenon has been observed for the PrLD containing RBP, Whi3, from the multinucleated filamentous fungus, Ashbya gossypii [16,61]. In vitro, Whi3 condensation is stimulated by the addition of a specific Whi3-bound transcript, CLN3 but not by the addition of preparations of total RNA. Reentrant LLPS behavior is observed for Whi3 as a function of both CLN3 and BNI1 transcript concentration. Thus, Whi3 droplets appear, grow in size, and then shrink as a function of increasing amounts of each transcript. Notably, the physical properties of Whi3 condensates, including how readily they fuse, differ depending on whether CLN3 of BNI1 is added [16], which has implications for the subcellular localization of these transcripts in vivo [16,17]. Both CLN3 and BNI1 harbor the same number of Whi3-binding sites with differences in the resulting condensate behavior owing to differences in the structure of each RNA, not the effective valency of the Whi3:RNA complexes [17]. This observation suggests an additional layer of complexity may regulate the reentrant phase behavior of RBPs in cells, with distinct RNAs modulating condensates with distinct properties and functions. One possibility is that the three-dimensional folds of specific RNAs act as structural scaffolds to bind and present RBPs in a specific spatial orientation relative to one another. Proximal arrangement of bound RBPs could favor interactions with one another in the same complex while more distal orientations could favor interactions with RBPs in the surrounding solution. Such distinct complexes could nucleate condensates with different compositions or material properties. Likewise, short RNAs lacking complex three-dimensional structure and high valency could tune RBP phase separation by acting to limit valency or reduce the effective concentration of the RBP available to multimerize on longer transcripts. This concept has been explored with another PrLD containing RBP, TDP-43 that exhibits reduced aggregation in cells treated with short ‘bait RNAs’ targeting TDP-43 [5].

Multi-layer condensates

Reentrant LLPS can manifest as condensates with layered topologies. This phenomenon has been modeled in vitro using RNA:protein and RNA:peptide mixtures that undergo a charge-mediated phase transition known as complex coacervation [4143,62]. In these studies, layered condensates emerge as a function of RNA:protein ratios, and the sequence composition of the components [4143,62]. A leading cause of the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is a hexanucleotide repeat expansion in the C9orf72 gene that can lead to the expression of arginine-containing dipeptide repeats (DPRs) [63]. Proline-arginine (PR) DPRs form spherical liquid coacervates in the presence of poly-A, poly-U and poly-C RNAs [62]. However, the addition of poly-G RNA which is capable of forming G-quadruplex structures, induces the formation of mesh like aggregates [62]. Additionally, mixing poly-A and poly-C RNA, and altering the ratio of this mixture relative to PR DPRs, yielded layered condensates with a core-shell architecture when poly-A:poly-C ratios were close to 1 [62]. Conversely, well mixed PR:RNA condensates formed when either RNA species was in excess over the other [62]. In addition to core-shell topology, protein-RNA reentrant LLPS can also create hollow condensates in certain protein:RNA regimes. This phenomenon has also been demonstrated for the ALS/FTD-linked RBP, FUS in the presence of poly-U RNA [42] which forms hollow condensates reminiscent of the vacuolated droplets formed by ALS/FTD-linked protein, TDP-43 when it is overexpressed in cells [64]. As these studies show, even simple two and three component reentrant systems can encode the formation of multi-layer condensates whose architecture responds to the concentration of each component. The extent to which such systems faithfully model complex cellular condensates composed of longer RNAs of more complex sequence, is an exciting area of future research. What is already apparent is that condensates exist in cells with features reminiscent of reentrant systems. One such condensate is the nucleolus, whose layered topology is intimately related to function [6567].

Nucleoli are bioreactors for ribosomal RNA (rRNA) transcription and ribosomal subunit assembly. They are also liquids, demixed from the surrounding nucleoplasm and maintained without an encompassing membrane [65,68]. Moreover, nucleoli are themselves a series of nested and immiscible liquids consisting of three layers [66]. The innermost layer is the fibrillar center (FC) where rRNA transcription occurs [66]. The FC is surrounded by the dense fibrillar center (DFC) rich in the protein fibrillarin and the site of rRNA processing [66]. The FC and DFC are nested with the granular component (GC) where ribosomes are assembled, which is enriched with the protein nucleophosmin [66]. Nucleophosmin and fibrillarin condensates can be reconstituted in vitro in the presence of rRNA [66,69]. Disrupting ATP-dependent processes, including transcription, in nucleoli in vivo alters their biophysical properties [66,68]. Further, blocking transcription with the drug actinomycin D causes nucleoli to shrink, as would be expected of a reentrant phase transition modulated by RNA [67]. The layered architecture of the nucleolus amounts to an assembly line that directs the assembly of mature ribosomal subunits and their flux out of the nucleolus [67]. Remarkably, the layered environment of the nucleolus may serve as an elaborate chaperone to ensure the correct assembly of rRNA into ribosomes [67]. Nascent rRNA is initially unfolded and accessible to protein binding by nucleolar RBPs and thus retention in a given nucleolar layer [67]. rRNA processing and folding gradually reduces the effective valency of rRNA for nucleolar RBPs and reduces retention in a given nucleolar layer, enabling partitioning into the next [67]. In this sense, the layered nucleolus may time the processing of rRNA and prevent premature flux out of the nucleolus before correct rRNA folding is achieved [67].

Biochemical timekeeping in transcription regulation

Might other examples of molecular timekeeping through reentrant phase separation occur in cells that tie the duration of a biochemical process to the existence or composition of a condensate? Protein-coding gene transcription can occur in condensates composed of transcription factors and coactivators [25,27,70,71] and the clustering of Pol II via its disordered CTD [24,7274]. The dynamics of such clusters are predictive of the output of transcription [71,75]. If one or more scaffolding components of a transcriptional condensate undergo reentrant phase separation tuned by RNA, bursts of active transcription at a given gene could be self-limiting.

This possibility has yet to be directly observed in live cells, yet compelling evidence exists that suggests self-limiting transcriptional activity may occur. For example, Yin Yang 1 (YY1) is a transcription factor (TF) with a zinc-finger DNA-binding domain that interacts with CTCF and serves to link enhancers to gene promoters to regulate transcription [76]. YY1 interacts with enhancers, which are proposed to be liquid compartments [25] and has an intrinsically disordered region (IDR). IDRs can facilitate LLPS when they harbor multivalent interaction motifs or ‘stickers’ [1,7779]. Notably, YY1 binds RNA in addition to DNA, and RNA binding promotes its localization to enhancers and active gene promoters with RNA facilitating enhanced DNA occupancy [80]. YY1 entrapment by nascent RNA could provide a local pool of YY1 at an active promoter, which could exchange with DNA in a feedback-loop to maintain transcriptional activity.

But what about gene shut off? A reentrant phase transition by YY1 regulated by nascent RNA from enhancers or promoters could provide a means to create the local pool of YY1 for DNA binding and continued activation, as well as enable shut-off when a threshold level of mRNA is produced (Figure 2). In this model, enhancer associated YY1 comes into proximity with a promoter, contributing to an enhancer-promoter loop and gene activation [76]. Nascent mRNA from the activated promoter recruits more YY1, nucleating a promoter-associated condensate, as has been observed for other transcription factors (Figure 2) [25,27,81]. As more RNA accumulates locally from the active gene, YY1:RNA interactions would become increasingly favored, ultimately leading to the dissolution of the YY1 condensate and downregulation of the associated promoter (Figure 2). YY1 binds active promoters broadly, and other DNA-binding TFs have also been shown to interact with RNA [80], suggesting that a self-limiting model for transcription activation through reentrant phase transitions could be a widespread phenomenon. Additional regulation of the reentrant phase could be encoded by the relative strength of TF:TF, TF:DNA, TF:RNA interactions and the number of TF-binding motifs present in a given promoter or associated nascent mRNA [82]. Likewise, pathologic transcription factors, such as those created by FUS PrLD fusion to DNA-binding domains, could escape such controls. Finally, altered ratios of components as a function of mRNA production and factor recruitment could not only dissolve the phase, but alter its composition as a function of time. This process would enable a transcriptional activation condensate to ‘mature’ into one harboring elongation and splicing machinery and perhaps ultimately termination machinery [24].

Gene transcription may provide a more complex example of reentrant behavior where condensate nucleation and dissolution could be governed by distinct polymers, poly-ADP ribose (PAR) and RNA. PAR has been implicated in transcription activation [83,84] and PAR chains mimic RNA and DNA to engage transcription factors [84,85]. Highly activated promoters of heat-shock genes become enmeshed in PAR chains which serve to recruit transcription machinery to the gene locus at levels in excess of those required to saturate the underlying DNA [84]. This finding led to the hypothesis that PAR cages create a ‘transcription compartment’ to drive robust heat shock gene expression [84]. This compartment could serve the dual role of shielding the heat-shock loci from the broader transcriptionally repressed environment of the nucleus during times of stress [84,85]. For cellular function to return to normal, stress-induced transcriptional programs must eventually give way to homeostatic ones. How might PAR-caged heat shock genes be shut off? One mechanism could involve degradation by PAR glycohydrolases [84]. Alternatively, the heat-shock transcription compartment itself may represent a reentrant condensate, nucleated by PAR but dissolved by RNA. This model is compelling as recent studies implicate PAR in nucleating FUS condensates at sites of DNA damage [86], and regulating cellular condensates more broadly [8789]. The extent to which sites of activated transcription represent liquid condensates nucleated by PAR, and the manner in which these condensates are regulated to tune gene output, are interesting areas of future research.

Unlike single-component LLPS, reentrant LLPS enables multiple additional layers of regulation and functionality. One feature is structure, with hollow or layered topologies capable of emerging from systems with few components. One example may be the multi-layered nucleolus, whose structure governs the biogenesis, processing and exportation of ribosomal subunits. Reentrant phases can also enable biochemical processes reliant on the phase to be timed and self-regulating. Biological timekeeping of transcriptional burst duration could be one process governed by reentrant behavior, particularly if TFs moonlight as RBPs. As the field seeks to identify functions associated with condensates, answering questions about how functional structures and cellular timekeeping mechanisms may emerge from reentrant phases is an exciting avenue for exploration.

Highlights:

  • Reentrant phase transitions involve a round trip between two material states

  • Reentrant liquid-liquid phase separation (LLPS) of proteins can be tuned by RNA

  • Reentrant LLPS can manifest as condensates with layered functional topologies

  • Reentrant LLPS may enable timekeeping via self-limiting reactions

Acknowledgements

We thank Joshua Riback, Ph.D. and Erik Martin, Ph.D. for thoughtful discussions on these and other concepts. B.P. is supported by the BrightFocus Foundation Postdoctoral Fellowship A2019612F. J.S. is supported by grants from Target ALS, ALSA, the Office of the Assistant Secretary of Defense for Health Affairs, through the Amyotrophic Lateral Sclerosis Research Program (W81XWH-20-1-0242), the G. Harold & Leila Y. Mathers Foundation, and NIH (R01GM099836, R21AG061784, and R21AG065854). J.S. is a consultant for Dewpoint Therapeutics and Maze Therapeutics.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Declaration of interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

J.S. is a consultant for Dewpoint Therapeutics and Maze Therapeutics.

B.P. and J.S. wrote the manuscript.

References

  • [1].Gomes E, Shorter J, The molecular language of membraneless organelles, J. Biol. Chem 294 (2019) 7115–7127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Boeynaems S, Alberti S, Fawzi NL, Mittag T, Polymenidou M, Rousseau F, Schymkowitz J, Shorter J, Wolozin B, Van Den Bosch L, Tompa P, Fuxreiter M, Protein Phase Separation: A New Phase in Cell Biology, Trends Cell Biol 28 (2018) 420–435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Patel A, Lee HO, Jawerth L, Maharana S, Jahnel M, Hein MY, Stoynov S, Mahamid J, Saha S, Franzmann TM, Pozniakovski A, Poser I, Maghelli N, Royer LA, Weigert M, Myers EW, Grill S, Drechsel D, Hyman AA, Alberti S, A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation, Cell 162 (2015) 1066–1077. [DOI] [PubMed] [Google Scholar]
  • [4].Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj AP, Kim HJ, Mittag T, Taylor JP, Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization, Cell 163 (2015) 123–133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis-Marks MR, Needham PG, Copley KE, Hurtle B, Portz B, Pyles NJ, Guo L, Calder CB, Wills ZP, Pandey UB, Kofler JK, Brodsky JL, Thathiah A, Shorter J, Donnelly CJ, RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43, Neuron 102 (2019) 321–338.e8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Kim HJ, Kim NC, Wang Y-D, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A, Kanagaraj AP, Carter R, Boylan KB, Wojtas AM, Rademakers R, Pinkus JL, Greenberg SA, Trojanowski JQ, Traynor BJ, Smith BN, Topp S, Gkazi A-S, Miller J, Shaw CE, Kottlors M, Kirschner J, Pestronk A, Li YR, Ford AF, Gitler AD, Benatar M, King OD, Kimonis VE, Ross ED, Weihl CC, Shorter J, Taylor JP, Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS, Nature 495 (2013) 467–473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Carlson CR, Asfaha JB, Ghent CM, Howard CJ, Hartooni N, Morgan DO, Phosphorylation modulates liquid-liquid phase separation of the SARS-CoV-2 N protein, BioRxiv (2020). 10.1101/2020.06.28.176248. [DOI] [Google Scholar]
  • [8].Perdikari TM, Murthy AC, Ryan VH, Watters S, Naik MT, Fawzi NL, SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins, (n.d.). 10.1101/2020.06.09.141101. [DOI]
  • [9].Cubuk J, Alston JJ, Incicco JJ, Singh S, Stuchell-Brereton MD, Ward MD, Zimmerman MI, Vithani N, Griffith D, Wagoner JA, Bowman GR, Hall KB, Soranno A, Holehouse AS, The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA, BioRxiv (2020). 10.1101/2020.06.17.158121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Iserman C, Roden C, Boerneke M, Sealfon R, McLaughlin G, Jungreis I, Park C, Boppana A, Fritch E, Hou YJ, Theesfeld C, Troyanskaya OG, Baric RS, Sheahan TP, Weeks K, Gladfelter AS, Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate, BioRxiv (2020). 10.1101/2020.06.11.147199. [DOI] [Google Scholar]
  • [11].Basu S, Mackowiak SD, Niskanen H, Knezevic D, Asimi V, Grosswendt S, Geertsema H, Ali S, Jerković I, Ewers H, Mundlos S, Meissner A, Ibrahim DM, Hnisz D, Unblending of Transcriptional Condensates in Human Repeat Expansion Disease, Cell 181 (2020) 1062–1079.e30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Li CH, Coffey EL, Dall’Agnese A, Hannett NM, Tang X, Henninger JE, Platt JM, Oksuz O, Zamudio AV, Afeyan LK, Schuijers J, Liu XS, Markoulaki S, Lungjangwa T, LeRoy G, Svoboda DS, Wogram E, Lee TI, Jaenisch R, Young RA, MeCP2 links heterochromatin condensates and neurodevelopmental disease, Nature (2020). 10.1038/s41586-020-2574-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Klein IA, Boija A, Afeyan LK, Hawken SW, Fan M, Dall’Agnese A, Oksuz O, Henninger JE, Shrinivas K, Sabari BR, Sagi I, Clark VE, Platt JM, Kar M, McCall PM, Zamudio AV, Manteiga JC, Coffey EL, Li CH, Hannett NM, Guo YE, Decker T-M, Lee TI, Zhang T, Weng J-K, Taatjes DJ, Chakraborty A, Sharp PA, Chang YT, Hyman AA, Gray NS, Young RA, Partitioning of cancer therapeutics in nuclear condensates, Science 368 (2020) 1386–1392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Shorter J, Prion-like Domains Program Ewing’s Sarcoma, Cell 171 (2017) 30–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Boulay G, Sandoval GJ, Riggi N, Iyer S, Buisson R, Naigles B, Awad ME, Rengarajan S, Volorio A, McBride MJ, Broye LC, Zou L, Stamenkovic I, Kadoch C, Rivera MN, Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain, Cell 171 (2017) 163–178.e19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Zhang H, Elbaum-Garfinkle S, Langdon EM, Taylor N, Occhipinti P, Bridges AA, Brangwynne CP, Gladfelter AS, RNA Controls PolyQ Protein Phase Transitions, Mol. Cell 60 (2015) 220–230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17].Langdon EM, Qiu Y, Niaki AG, McLaughlin GA, Weidmann CA, Gerbich TM, Smith JA, Crutchley JM, Termini CM, Weeks KM, Myong S, Gladfelter AS, mRNA structure determines specificity of a polyQ-driven phase separation, Science 360 (2018) 922–927. 10.1126/science.aar7432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].Smith J, Calidas D, Schmidt H, Lu T, Rasoloson D, Seydoux G, Spatial patterning of P granules by RNA-induced phase separation of the intrinsically-disordered protein MEG-3, Elife 5 (2016). 10.7554/eLife.21337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Case LB, Zhang X, Ditlev JA, Rosen MK, Stoichiometry controls activity of phase-separated clusters of actin signaling proteins, Science 363 (2019) 1093–1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [20].Huang WYC, Alvarez S, Kondo Y, Lee YK, Chung JK, Lam HYM, Biswas KH, Kuriyan J, Groves JT, A molecular assembly phase transition and kinetic proofreading modulate Ras activation by SOS, Science 363 (2019) 1098–1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Larson AG, Elnatan D, Keenen MM, Trnka MJ, Johnston JB, Burlingame AL, Agard DA, Redding S, Narlikar GJ, Liquid droplet formation by HP1α suggests a role for phase separation in heterochromatin, Nature 547 (2017) 236–240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Strom AR, Emelyanov AV, Mir M, Fyodorov DV, Darzacq X, Karpen GH, Phase separation drives heterochromatin domain formation, Nature 547 (2017) 241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Cai D, Feliciano D, Dong P, Flores E, Gruebele M, Porat-Shliom N, Sukenik S, Liu Z, Lippincott-Schwartz J, Phase separation of YAP reorganizes genome topology for long-term YAP target gene expression, Nat. Cell Biol 21 (2019) 1578–1589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Guo YE, Manteiga JC, Henninger JE, Sabari BR, Dall’Agnese A, Hannett NM, Spille J-H, Afeyan LK, Zamudio AV, Shrinivas K, Abraham BJ, Boija A, Decker T-M, Rimel JK, Fant CB, Lee TI, Cisse II, Sharp PA, Taatjes DJ, Young RA, Pol II phosphorylation regulates a switch between transcriptional and splicing condensates, Nature 572 (2019) 543–548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Sabari BR, Dall’Agnese A, Boija A, Klein IA, Coffey EL, Shrinivas K, Abraham BJ, Hannett NM, Zamudio AV, Manteiga JC, Li CH, Guo YE, Day DS, Schuijers J, Vasile E, Malik S, Hnisz D, Lee TI, Cisse II, Roeder RG, Sharp PA, Chakraborty AK, Young RA, Coactivator condensation at super-enhancers links phase separation and gene control, Science 361 (2018). 10.1126/science.aar3958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Ladouceur A-M, Parmar BS, Biedzinski S, Wall J, Graydon Tope S, Cohn D, Kim A, Soubry N, Reyes-Lamothe R, Weber SC, Clusters of bacterial RNA polymerase are biomolecular condensates that assemble through liquid–liquid phase separation, Proceedings of the National Academy of Sciences 117 (2020) 18540–18549. 10.1073/pnas.2005019117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Boija A, Klein IA, Sabari BR, Dall’Agnese A, Coffey EL, Zamudio AV, Li CH, Shrinivas K, Manteiga JC, Hannett NM, Abraham BJ, Afeyan LK, Guo YE, Rimel JK, Fant CB, Schuijers J, Lee TI, Taatjes DJ, Young RA, Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains, Cell 175 (2018) 1842–1855.e16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Dorone Y, Boeynaems S, Jin B, Bossi F, Flores E, Lazarus E, Michiels E, De Decker M, Baatsen P, Holehouse AS, Sukenik S, Gitler AD, Rhee SY, Hydration-dependent phase separation of a prion-like protein regulates seed germination during water stress, (n.d.). 10.1101/2020.08.07.242172. [DOI] [PMC free article] [PubMed]
  • [29].Riback JA, Katanski CD, Kear-Scott JL, Pilipenko EV, Rojek AE, Sosnick TR, Drummond DA, Stress-Triggered Phase Separation Is an Adaptive, Evolutionarily Tuned Response, Cell 168 (2017) 1028–1040.e19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Frazer C, Staples MI, Kim Y, Hirakawa M, Dowell MA, Johnson NV, Hernday AD, Ryan VH, Fawzi NL, Finkelstein IJ, Bennett RJ, Epigenetic cell fate in Candida albicans is controlled by transcription factor condensates acting at super-enhancer-like elements, Nat Microbiol (2020). 10.1038/s41564-020-0760-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [31].Chakravarty AK, Smejkal T, Itakura AK, Garcia DM, Jarosz DF, A Non-amyloid Prion Particle that Activates a Heritable Gene Expression Program, Mol. Cell 77 (2020) 251–265.e9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Ma W, Mayr C, A Membraneless Organelle Associated with the Endoplasmic Reticulum Enables 3’UTR-Mediated Protein-Protein Interactions, Cell 175 (2018) 1492–1506.e19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Zhao H, Chiaro CR, Zhang L, Smith PB, Chan CY, Pedley AM, Pugh RJ, French JB, Patterson AD, Benkovic SJ, Quantitative analysis of purine nucleotides indicates that purinosomes increase de novo purine biosynthesis, J. Biol. Chem 290 (2015) 6705–6713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Reinhardt A, Williamson AJ, Doye JPK, Carrete J, Varela LM, Louis AA, Re-entrant phase behavior for systems with competition between phase separation and self-assembly, The Journal of Chemical Physics 134 (2011) 104905. 10.1063/1.3557059. [DOI] [PubMed] [Google Scholar]
  • [35].Narayanan T, Kumar A, Reentrant phase transitions in multicomponent liquid mixtures, Physics Reports 249 (1994) 135–218. 10.1016/0370-1573(94)90015-9. [DOI] [Google Scholar]
  • [36].Milin AN, Deniz AA, Reentrant Phase Transitions and Non-Equilibrium Dynamics in Membraneless Organelles, Biochemistry 57 (2018) 2470–2477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [37].Alberti S, Gladfelter A, Mittag T, Considerations and Challenges in Studying Liquid-Liquid Phase Separation and Biomolecular Condensates, Cell 176 (2019) 419–434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [38].Sabari BR, Dall’Agnese A, Young RA, Biomolecular Condensates in the Nucleus, Trends Biochem. Sci (2020). 10.1016/j.tibs.2020.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [39].Roden C, Gladfelter AS, RNA contributions to the form and function of biomolecular condensates, Nat. Rev. Mol. Cell Biol (2020). 10.1038/s41580-020-0264-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [40].Tauber D, Tauber G, Parker R, Mechanisms and Regulation of RNA Condensation in RNP Granule Formation, Trends in Biochemical Sciences (2020). 10.1016/j.tibs.2020.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [41].Aumiller WM Jr, Keating CD, Phosphorylation-mediated RNA/peptide complex coacervation as a model for intracellular liquid organelles, Nat. Chem 8 (2016) 129–137. [DOI] [PubMed] [Google Scholar]
  • [42].Banerjee PR, Milin AN, Moosa MM, Onuchic PL, Deniz AA, Reentrant Phase Transition Drives Dynamic Substructure Formation in Ribonucleoprotein Droplets, Angew. Chem. Int. Ed Engl 56 (2017) 11354–11359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [43].Alshareedah I, Moosa MM, Raju M, Potoyan DA, Banerjee PR, Phase transition of RNA–protein complexes into ordered hollow condensates, Proceedings of the National Academy of Sciences 117 (2020) 15650–15658. 10.1073/pnas.1922365117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Banani SF, Rice AM, Peeples WB, Lin Y, Jain S, Parker R, Rosen MK, Compositional control of phase-separated cellular bodies, Cell 166 (2016) 651–663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [45].Heidenreich M, Georgeson JM, Locatelli E, Rovigatti L, Nandi SK, Steinberg A, Nadav Y, Shimoni E, Safran SA, Doye JPK, Levy ED, Designer protein assemblies with tunable phase diagrams in living cells, Nat. Chem. Biol 16 (2020) 939–945. [DOI] [PubMed] [Google Scholar]
  • [46].Nguyen TT, Rouzina I, Shklovskii BI, Reentrant condensation of DNA induced by multivalent counterions, J. Chem. Phys 112 (2000) 2562–2568. [Google Scholar]
  • [47].Teif VB, Bohinc K, Condensed DNA: condensing the concepts, Prog. Biophys. Mol. Biol 105 (2011) 208–222. [DOI] [PubMed] [Google Scholar]
  • [48].Harrison AF, Shorter J, RNA-binding proteins with prion-like domains in health and disease, Biochem. J 474 (2017) 1417–1438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [49].Cushman M, Johnson BS, King OD, Gitler AD, Shorter J, Prion-like disorders: blurring the divide between transmissibility and infectivity, J. Cell Sci 123 (2010) 1191–1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [50].King OD, Gitler AD, Shorter J, The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease, Brain Res 1462 (2012) 61–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [51].Li YR, King OD, Shorter J, Gitler AD, Stress granules as crucibles of ALS pathogenesis, J. Cell Biol 201 (2013) 361–372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [52].March ZM, King OD, Shorter J, Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease, Brain Res 1647 (2016) 9–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [53].Crozat A, Åman P, Mandahl N, Ron D, Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma, Nature 363 (1993) 640–644. 10.1038/363640a0. [DOI] [PubMed] [Google Scholar]
  • [54].Rabbitts TH, Forster A, Larson R, Nathan P, Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma, Nature Genetics 4 (1993) 175–180. 10.1038/ng0693-175. [DOI] [PubMed] [Google Scholar]
  • [55].Schwartz JC, Wang X, Podell ER, Cech TR, RNA seeds higher-order assembly of FUS protein, Cell Rep 5 (2013) 918–925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [56].Kwon I, Kato M, Xiang S, Wu L, Theodoropoulos P, Mirzaei H, Han T, Xie S, Corden JL, McKnight SL, Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains, Cell 155 (2013) 1049–1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [57].Thompson VF, Victor RA, Morera AA, Moinpour M, Liu MN, Kisiel CC, Pickrel K, Springhower CE, Schwartz JC, Transcription-Dependent Formation of Nuclear Granules Containing FUS and RNA Pol II, Biochemistry 57 (2018) 7021–7032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [58].Burke KA, Janke AM, Rhine CL, Fawzi NL, Residue-by-Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II, Mol. Cell 60 (2015) 231–241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [59].Shin Y, Berry J, Pannucci N, Haataja MP, Toettcher JE, Brangwynne CP, Spatiotemporal Control of Intracellular Phase Transitions Using Light-Activated optoDroplets, Cell 168 (2017) 159–171.e14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [60].Maharana S, Wang J, Papadopoulos DK, Richter D, Pozniakovsky A, Poser I, Bickle M, Rizk S, Guillén-Boixet J, Franzmann TM, Jahnel M, Marrone L, Chang Y-T, Sterneckert J, Tomancak P, Hyman AA, Alberti S, RNA buffers the phase separation behavior of prion-like RNA binding proteins, Science 360 (2018) 918–921. 10.1126/science.aar7366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [61].Guo L, Shorter J, It’s Raining Liquids: RNA Tunes Viscoelasticity and Dynamics of Membraneless Organelles, Mol. Cell 60 (2015) 189–192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [62].Boeynaems S, Holehouse AS, Weinhardt V, Kovacs D, Van Lindt J, Larabell C, Van Den Bosch L, Das R, Tompa P, Pappu RV, Gitler A, Spontaneous driving forces give rise to protein-RNA condensates with coexisting phases and complex material properties, Proc. Natl. Acad. Sci. U. S. A 116 (2019) 7889–7898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [63].Odeh HM, Shorter J, Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS/FTD, Emerg Top Life Sci (2020). 10.1042/ETLS20190167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [64].Schmidt HB, Rohatgi R, In Vivo Formation of Vacuolated Multi-phase Compartments Lacking Membranes, Cell Reports 16 (2016) 1228–1236. 10.1016/j.celrep.2016.06.088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [65].Weber SC, Brangwynne CP, Inverse size scaling of the nucleolus by a concentration-dependent phase transition, Curr. Biol 25 (2015) 641–646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [66].Feric M, Vaidya N, Harmon TS, Mitrea DM, Zhu L, Richardson TM, Kriwacki RW, Pappu RV, Brangwynne CP, Coexisting Liquid Phases Underlie Nucleolar Subcompartments, Cell 165 (2016) 1686–1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [67].Riback JA, Zhu L, Ferrolino MC, Tolbert M, Mitrea DM, Sanders DW, Wei M-T, Kriwacki RW, Brangwynne CP, Composition-dependent thermodynamics of intracellular phase separation, Nature 581 (2020) 209–214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [68].Brangwynne CP, Mitchison TJ, Hyman AA, Active liquid-like behavior of nucleoli determines their size and shape in Xenopus laevis oocytes, Proceedings of the National Academy of Sciences 108 (2011) 4334–4339. 10.1073/pnas.1017150108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [69].Mitrea DM, Cika JA, Guy CS, Ban D, Banerjee PR, Stanley CB, Nourse A, Deniz AA, Kriwacki RW, Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins displaying R-rich linear motifs and rRNA, Elife 5 (2016). 10.7554/eLife.13571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [70].Lu F, Portz B, Gilmour DS, The C-Terminal Domain of RNA Polymerase II Is a Multivalent Targeting Sequence that Supports Drosophila Development with Only Consensus Heptads, Mol. Cell 73 (2019) 1232–1242.e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [71].Cho W-K, Spille J-H, Hecht M, Lee C, Li C, Grube V, Cisse II, Mediator and RNA polymerase II clusters associate in transcription-dependent condensates, Science 361 (2018) 412–415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [72].Portz B, Shorter J, Switching Condensates: The CTD Code Goes Liquid, Trends Biochem. Sci 45 (2020) 1–3. [DOI] [PubMed] [Google Scholar]
  • [73].Cisse II, Izeddin I, Causse SZ, Boudarene L, Senecal A, Muresan L, Dugast-Darzacq C, Hajj B, Dahan M, Darzacq X, Real-time dynamics of RNA polymerase II clustering in live human cells, Science 341 (2013) 664–667. [DOI] [PubMed] [Google Scholar]
  • [74].Boehning M, Dugast-Darzacq C, Rankovic M, Hansen AS, Yu T, Marie-Nelly H, McSwiggen DT, Kokic G, Dailey GM, Cramer P, Darzacq X, Zweckstetter M, RNA polymerase II clustering through carboxy-terminal domain phase separation, Nat. Struct. Mol. Biol 25 (2018) 833–840. [DOI] [PubMed] [Google Scholar]
  • [75].Cho W-K, Jayanth N, English BP, Inoue T, Andrews JO, Conway W, Grimm JB, Spille J-H, Lavis LD, Lionnet T, Cisse II, RNA Polymerase II cluster dynamics predict mRNA output in living cells, Elife 5 (2016). 10.7554/elife.13617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [76].Weintraub AS, Li CH, Zamudio AV, Sigova AA, Hannett NM, Day DS, Abraham BJ, Cohen MA, Nabet B, Buckley DL, Guo YE, Hnisz D, Jaenisch R, Bradner JE, Gray NS, Young RA, YY1 Is a Structural Regulator of Enhancer-Promoter Loops, Cell 171 (2017) 1573–1588.e28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [77].Harmon TS, Holehouse AS, Rosen MK, Pappu RV, Intrinsically disordered linkers determine the interplay between phase separation and gelation in multivalent proteins, Elife 6 (2017). 10.7554/eLife.30294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [78].Martin EW, Holehouse AS, Peran I, Farag M, Incicco JJ, Bremer A, Grace CR, Soranno A, Pappu RV, Mittag T, Valence and patterning of aromatic residues determine the phase behavior of prion-like domains, Science 367 (2020) 694–699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [79].Choi J-M, Holehouse AS, Pappu RV, Physical principles underlying the complex biology of intracellular phase transitions, Annu. Rev. Biophys 49 (2020) 107–133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [80].Sigova AA, Abraham BJ, Ji X, Molinie B, Hannett NM, Guo YE, Jangi M, Giallourakis CC, Sharp PA, Young RA, Transcription factor trapping by RNA in gene regulatory elements, Science 350 (2015) 978–981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [81].Zamudio AV, Dall’Agnese A, Henninger JE, Manteiga JC, Afeyan LK, Hannett NM, Coffey EL, Li CH, Oksuz O, Sabari BR, Boija A, Klein IA, Hawken SW, Spille J-H, Decker T-M, Cisse II, Abraham BJ, Lee TI, Taatjes DJ, Schuijers J, Young RA, Mediator Condensates Localize Signaling Factors to Key Cell Identity Genes, Mol. Cell 76 (2019) 753–766.e6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [82].Alshareedah I, Kaur T, Ngo J, Seppala H, Kounatse L-AD, Wang W, Moosa MM, Banerjee PR, Interplay between short-range attraction and long-range repulsion controls reentrant liquid condensation of ribonucleoprotein-RNA complexes, J. Am. Chem. Soc 141 (2019) 14593–14602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [83].Kraus WL, Lis JT, PARP goes transcription, Cell 113 (2003) 677–683. [DOI] [PubMed] [Google Scholar]
  • [84].Zobeck KL, Buckley MS, Zipfel WR, Lis JT, Recruitment timing and dynamics of transcription factors at the Hsp70 loci in living cells, Mol. Cell 40 (2010) 965–975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [85].Kantidze OL, Velichko AK, Razin SV, Heat Stress-Induced Transcriptional Repression, Biochemistry. 80 (2015) 990–993. [DOI] [PubMed] [Google Scholar]
  • [86].Altmeyer M, Neelsen KJ, Teloni F, Pozdnyakova I, Pellegrino S, Grøfte M, Rask M-BD, Streicher W, Jungmichel S, Nielsen ML, Lukas J, Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose), Nat. Commun 6 (2015) 8088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [87].McGurk L, Gomes E, Guo L, Mojsilovic-Petrovic J, Tran V, Kalb RG, Shorter J, Bonini NM, Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization, Mol. Cell 71 (2018) 703–717.e9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [88].Leung AKL, Poly(ADP-ribose): A Dynamic Trigger for Biomolecular Condensate Formation, Trends Cell Biol 30 (2020) 370–383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [89].McGurk L, Gomes E, Guo L, Shorter J, Bonini NM, Poly(ADP-ribose) Engages the TDP-43 Nuclear-Localization Sequence to Regulate Granulo-Filamentous Aggregation, Biochemistry 57 (2018) 6923–6926. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES